PPP1R12A antibody (C-Term)
Quick Overview for PPP1R12A antibody (C-Term) (ABIN926675)
Target
See all PPP1R12A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purification
- Purified
-
Immunogen
- PPP1 R11 antibody was raised in rabbit using the C terminal of PPP1 11 as the immunogen
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator.
-
Comment
-
PPP1R12A Blocking Peptide, (ABIN5615508), is also available for use as a blocking control in assays to test for specificity of this PPP1R12A antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PPP1R12A (Myosin Phosphatase, Target Subunit 1 (PPP1R12A))
-
Alternative Name
- PPP1R12A
-
Background
- Myosin phosphatase target subunit 1, which is also called the myosin-binding subunit of myosin phosphatase, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Synonyms: Polyclonal PPP1R12A antibody, Anti-PPP1R12A antibody, protein phosphatase 1, regulatory, inhibitor subunit 12A antibody, MBS antibody, MGC133042 antibody, MYPT1 antibody.
-
Pathways
- M Phase
Target
-